Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation (AF) is a prevalent cardiac arrhythmia characterized by irregular and frequently rapid electrical activity in the atria.
Frontier Medicines raises $80M, enters clinic and eyes potential IPO in Q4 or early 2025
Frontier Medicines, a bicoastal biotech creating covalent small molecules, has secured $80 million in Series C funds and dosed the first patient in its initial